$ABIO • Had a $9.4M direct offering at $9.00 per-share (348k shares), with warrants for an additional 694k shares at $8.99. This gives ABIO operating funds to develop their CV-19 treatment and continue work on their vaccine candidate. No company invests $9.4M in a company who doesn't expect to get their many back - a substantial return. And lastly ABIO newfound financial freedom gives them more leverage should a buyout offer occur. I love the chart setup indicating a reversal, and am bullish in the short and long term, EOW PT $7.25
  • 3